Georgia Healthcare Group (LON:GHG) had its price target boosted by Jefferies Group from GBX 370 ($4.98) to GBX 400 ($5.38) in a research note issued to investors on Monday. The firm currently has a “buy” rating on the stock. Jefferies Group’s price objective would suggest a potential upside of 14.00% from the company’s current price.
Several other equities research analysts have also commented on GHG. Numis Securities restated an “add” rating and set a GBX 420 ($5.65) target price on shares of Georgia Healthcare Group in a research report on Tuesday, August 15th. Berenberg Bank initiated coverage on Georgia Healthcare Group in a report on Tuesday, August 22nd. They issued a “buy” rating and a GBX 504 ($6.78) price target on the stock.
Shares of Georgia Healthcare Group (GHG) opened at GBX 350.88 ($4.72) on Monday. Georgia Healthcare Group has a 52-week low of GBX 290 ($3.90) and a 52-week high of GBX 403.50 ($5.43).
About Georgia Healthcare Group
Georgia Healthcare Group PLC is a United Kingdom-based holding company. The Company provides healthcare services in Georgian healthcare services market. The Company operates in two segments based on products and services: Healthcare services and Medical insurance. The Company’s Healthcare services are the inpatient and outpatient medical services delivered by the referral hospitals, community hospitals and ambulatory clinics owned by the Company throughout the Georgian territory.
Receive News & Ratings for Georgia Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Georgia Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.